Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women
- PMID: 22162057
- PMCID: PMC3244839
- DOI: 10.1002/ana.22468
Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women
Abstract
Objective: Previous cross-sectional studies have observed alterations in activity rhythms in dementia patients but the direction of causation is unclear. We determined whether circadian activity rhythms measured in community-dwelling older women are prospectively associated with incident dementia or mild cognitive impairment (MCI).
Methods: Activity rhythm data were collected from 1,282 healthy community-dwelling women from the Study of Osteoporotic Fractures (SOF) cohort (mean age 83 years) with wrist actigraphy for a minimum of three 24-hour periods. Each participant completed a neuropsychological test battery and had clinical cognitive status (dementia, MCI, normal) adjudicated by an expert panel approximately 5 years later. All analyses were adjusted for demographics, body mass index (BMI), functional status, depression, medications, alcohol, caffeine, smoking, health status, and comorbidities.
Results: After 4.9 years of follow-up, 195 (15%) women had developed dementia and 302 (24%) had developed MCI. Older women with decreased activity rhythms had a higher likelihood of developing dementia or MCI when comparing those in the lowest quartiles of amplitude (odds ratio [OR] = 1.57; 95% CI, 1.09-2.25) or rhythm robustness (OR = 1.57; 95% CI, 1.10-2.26) to women in the highest quartiles. An increased risk of dementia or MCI (OR = 1.83; 95% CI, 1.29-2.61) was found for women whose timing of peak activity occurred later in the day (after 3:51 PM) when compared to those with average timing (1:34 PM-3:51 PM).
Interpretation: Older, healthy women with decreased circadian activity rhythm amplitude and robustness, and delayed rhythms have increased odds of developing dementia and MCI. If confirmed, future studies should examine whether interventions (physical activity, bright light exposure) that influence activity rhythms will reduce the risk of cognitive deterioration in the elderly.
Copyright © 2011 American Neurological Association.
Conflict of interest statement
KE Ensrud is a federal employee of the Veterans Affairs Medical Center in Minneapolis, MN and has received research support from California Pacific Medical Center, who receives funding from Roche Molecular Systems.
S Cummings, K Stone, T Blackwell and G Tranah are employees of the California Pacific Medical Center and receive research support from Roche Molecular Systems.
S Ancoli-Israel has disclosed that she has received grants for educational activities from Sepracor, and Litbebook, Inc. She has served as an advisor or consultant to Ferring Pharmaceuticals Inc., GlaxoSmithKline, Merck, NeuroVigil, Inc., Neurocrine Biosciences, Pfizer, Philips Respironics, sanofi-aventis, Sepracor, Inc., Schering-Plough.
M Paudel, S Redline and T Hillier have no conflicts of interest.
Comment in
-
Sleep, circadian rhythms, and dementia.Ann Neurol. 2011 Nov;70(5):677-9. doi: 10.1002/ana.22637. Ann Neurol. 2011. PMID: 22162052 No abstract available.
References
-
- Chaudhury D, Colwell CS. Circadian modulation of learning and memory in fear-conditioned mice. Behav Brain Res. 2002;133:95–108. - PubMed
-
- Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28:403–450. - PubMed
-
- Usher M, Cohen JD, Servan-Schreiber D, et al. The role of locus coeruleus in the regulation of cognitive performance. Science. 1999;283:549–554. - PubMed
-
- Kripke DF, Youngstedt SD, Elliott JA, et al. Circadian phase in adults of contrasting ages. Chronobiol Int. 2005;22:695–709. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG008415/AG/NIA NIH HHS/United States
- AG05407/AG/NIA NIH HHS/United States
- R01 AR035583/AR/NIAMS NIH HHS/United States
- AG05394/AG/NIA NIH HHS/United States
- AG005394-22A1/AG/NIA NIH HHS/United States
- AG027576-22/AG/NIA NIH HHS/United States
- AR35583/AR/NIAMS NIH HHS/United States
- AG005407/AG/NIA NIH HHS/United States
- R01 AG030474/AG/NIA NIH HHS/United States
- R01 AR035582/AR/NIAMS NIH HHS/United States
- AG026720/AG/NIA NIH HHS/United States
- R01 AG027574/AG/NIA NIH HHS/United States
- AR35582/AR/NIAMS NIH HHS/United States
- R01 AG026720/AG/NIA NIH HHS/United States
- R01 AR035584/AR/NIAMS NIH HHS/United States
- AG027574-22A1/AG/NIA NIH HHS/United States
- R01 AG027576/AG/NIA NIH HHS/United States
- AG030474/AG/NIA NIH HHS/United States
- K24 AG031155/AG/NIA NIH HHS/United States
- R01 AG005407/AG/NIA NIH HHS/United States
- AG08415/AG/NIA NIH HHS/United States
- R01 AR046238/AR/NIAMS NIH HHS/United States
- R01 AG005394/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical